Acrivon Therapeutics, Inc. (ACRV): Shares Outstanding

Annual figures by period end, from SEC filings.

31.65M
As of 2025-12-31
42.85M
As of 2026-06-30
+13.0%
3-year compound annual growth
2021-12-31: 1.77M2022-12-31: 21.92M2023-12-31: 22.52M2024-12-31: 31.23M2025-12-31: 31.65M31.65M
2021-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3131.65M+1.3%2026-03-19, Balance as of period end
2024-12-3131.23M+38.7%2026-03-19, Balance as of period end
2023-12-3122.52M+2.7%2025-03-27, Balance as of period end
2022-12-3121.92Mn/m2024-03-28, Balance as of period end
2021-12-311.77Mn/a2023-03-28, Balance as of period end